Pharma Mar SA
OTC:PHMMF
Income Statement
Earnings Waterfall
Pharma Mar SA
Revenue
|
158.2m
EUR
|
Cost of Revenue
|
-9.6m
EUR
|
Gross Profit
|
148.5m
EUR
|
Operating Expenses
|
-152.6m
EUR
|
Operating Income
|
-4.1m
EUR
|
Other Expenses
|
5.2m
EUR
|
Net Income
|
1.1m
EUR
|
Income Statement
Pharma Mar SA
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
142
N/A
|
145
+2%
|
149
+2%
|
149
+1%
|
175
+17%
|
186
+7%
|
191
+3%
|
204
+7%
|
194
-5%
|
190
-2%
|
191
+0%
|
187
-2%
|
181
-3%
|
184
+2%
|
186
+1%
|
182
-2%
|
159
-13%
|
141
-11%
|
128
-9%
|
107
-16%
|
109
+1%
|
100
-8%
|
84
-17%
|
82
-2%
|
86
+4%
|
166
+93%
|
214
+29%
|
246
+15%
|
270
+10%
|
222
-18%
|
200
-10%
|
188
-6%
|
230
+22%
|
228
-1%
|
229
+0%
|
227
-1%
|
196
-14%
|
177
-10%
|
175
-1%
|
173
-1%
|
158
-8%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(34)
|
(34)
|
(35)
|
(35)
|
(41)
|
(42)
|
(45)
|
(48)
|
(46)
|
(48)
|
(46)
|
(46)
|
(44)
|
(45)
|
(46)
|
(45)
|
(35)
|
(25)
|
(11)
|
(1)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(11)
|
(14)
|
(18)
|
(17)
|
(14)
|
(16)
|
(12)
|
(14)
|
(13)
|
(14)
|
(12)
|
(10)
|
(13)
|
(10)
|
|
Gross Profit |
108
N/A
|
111
+3%
|
114
+2%
|
115
+1%
|
134
+17%
|
144
+8%
|
146
+1%
|
156
+7%
|
148
-5%
|
143
-4%
|
145
+2%
|
141
-2%
|
137
-3%
|
140
+2%
|
140
+0%
|
136
-3%
|
124
-9%
|
116
-6%
|
117
+1%
|
107
-9%
|
104
-3%
|
95
-8%
|
78
-18%
|
77
-2%
|
81
+5%
|
160
+98%
|
207
+30%
|
235
+13%
|
256
+9%
|
204
-20%
|
182
-11%
|
175
-4%
|
213
+22%
|
216
+1%
|
215
-1%
|
215
0%
|
183
-15%
|
165
-10%
|
165
0%
|
159
-3%
|
149
-7%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(89)
|
(91)
|
(93)
|
(92)
|
(114)
|
(134)
|
(139)
|
(147)
|
(137)
|
(145)
|
(149)
|
(152)
|
(156)
|
(154)
|
(154)
|
(154)
|
(143)
|
(139)
|
(133)
|
(123)
|
(120)
|
(116)
|
(108)
|
(105)
|
(98)
|
(98)
|
(96)
|
(97)
|
(100)
|
(100)
|
(103)
|
(104)
|
(121)
|
(120)
|
(128)
|
(130)
|
(138)
|
(143)
|
(148)
|
(155)
|
(153)
|
|
Selling, General & Administrative |
(61)
|
(61)
|
(62)
|
(60)
|
(60)
|
(60)
|
(61)
|
(65)
|
(67)
|
(70)
|
(70)
|
(68)
|
(66)
|
(67)
|
(68)
|
(67)
|
(56)
|
(51)
|
(44)
|
(37)
|
(37)
|
(39)
|
(38)
|
(38)
|
(36)
|
(39)
|
(38)
|
(37)
|
(34)
|
(35)
|
(35)
|
(34)
|
(38)
|
(37)
|
(38)
|
(39)
|
(42)
|
(42)
|
(43)
|
(45)
|
(40)
|
|
Research & Development |
(43)
|
(43)
|
(45)
|
(48)
|
(46)
|
(48)
|
(51)
|
(52)
|
(59)
|
(66)
|
(71)
|
(75)
|
(77)
|
(78)
|
(77)
|
(77)
|
(78)
|
(81)
|
(82)
|
(80)
|
(69)
|
(69)
|
(61)
|
(58)
|
(46)
|
(48)
|
(47)
|
(48)
|
(50)
|
(56)
|
(58)
|
(61)
|
(70)
|
(75)
|
(82)
|
(82)
|
(81)
|
(85)
|
(90)
|
(97)
|
(97)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(4)
|
|
Other Operating Expenses |
14
|
14
|
14
|
16
|
(7)
|
(26)
|
(27)
|
(29)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(7)
|
(7)
|
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(8)
|
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(10)
|
(9)
|
(9)
|
(7)
|
(7)
|
(9)
|
(12)
|
(15)
|
(15)
|
(13)
|
(12)
|
|
Operating Income |
19
N/A
|
21
+9%
|
21
+2%
|
22
+6%
|
20
-9%
|
10
-50%
|
7
-30%
|
10
+34%
|
11
+19%
|
(2)
N/A
|
(4)
-78%
|
(11)
-151%
|
(19)
-73%
|
(15)
+22%
|
(14)
+5%
|
(18)
-27%
|
(20)
-11%
|
(22)
-13%
|
(16)
+30%
|
(16)
-5%
|
(16)
+2%
|
(21)
-30%
|
(29)
-41%
|
(28)
+6%
|
(17)
+37%
|
62
N/A
|
111
+79%
|
138
+24%
|
156
+13%
|
104
-34%
|
79
-24%
|
70
-11%
|
92
+31%
|
96
+4%
|
87
-10%
|
85
-2%
|
44
-48%
|
22
-50%
|
17
-25%
|
4
-74%
|
(4)
N/A
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(6)
|
(3)
|
(4)
|
(5)
|
(6)
|
(4)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(7)
|
(11)
|
(7)
|
(9)
|
(3)
|
2
|
1
|
5
|
5
|
(1)
|
(3)
|
(4)
|
(5)
|
(4)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(3)
|
(3)
|
(2)
|
0
|
(3)
|
(3)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
4
|
|
Pre-Tax Income |
14
N/A
|
15
+9%
|
16
+7%
|
17
+7%
|
14
-17%
|
4
-73%
|
1
-79%
|
3
+310%
|
6
+76%
|
(8)
N/A
|
(10)
-32%
|
(17)
-67%
|
(25)
-46%
|
(21)
+17%
|
(19)
+7%
|
(23)
-19%
|
(25)
-9%
|
(27)
-10%
|
(20)
+26%
|
(21)
-2%
|
(20)
+3%
|
(25)
-25%
|
(33)
-34%
|
(31)
+6%
|
(22)
+31%
|
59
N/A
|
109
+84%
|
132
+20%
|
146
+11%
|
97
-34%
|
70
-28%
|
68
-2%
|
95
+40%
|
97
+2%
|
91
-6%
|
90
-1%
|
44
-51%
|
20
-54%
|
12
-38%
|
0
-100%
|
(4)
N/A
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
0
|
(1)
|
1
|
1
|
1
|
1
|
(4)
|
(1)
|
0
|
(7)
|
3
|
(0)
|
(3)
|
4
|
12
|
12
|
14
|
15
|
(8)
|
(6)
|
(3)
|
(5)
|
(2)
|
(4)
|
(4)
|
(4)
|
6
|
9
|
8
|
9
|
5
|
|
Income from Continuing Operations |
12
|
13
|
14
|
15
|
13
|
3
|
(0)
|
3
|
7
|
(7)
|
(10)
|
(18)
|
(24)
|
(19)
|
(18)
|
(22)
|
(28)
|
(28)
|
(20)
|
(28)
|
(17)
|
(25)
|
(37)
|
(28)
|
(9)
|
72
|
124
|
147
|
137
|
91
|
67
|
63
|
93
|
93
|
87
|
86
|
49
|
29
|
21
|
9
|
1
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
11
N/A
|
12
+10%
|
14
+10%
|
15
+8%
|
13
-11%
|
3
-79%
|
(0)
N/A
|
3
N/A
|
7
+101%
|
(7)
N/A
|
(10)
-40%
|
(18)
-78%
|
(24)
-36%
|
(19)
+19%
|
(18)
+6%
|
(22)
-20%
|
(27)
-22%
|
(26)
+4%
|
(16)
+37%
|
(13)
+18%
|
(6)
+59%
|
(15)
-166%
|
(30)
-103%
|
(31)
-5%
|
(11)
+64%
|
70
N/A
|
124
+78%
|
147
+19%
|
137
-6%
|
91
-34%
|
67
-27%
|
61
-9%
|
93
+53%
|
91
-2%
|
85
-7%
|
82
-4%
|
49
-39%
|
29
-42%
|
21
-28%
|
14
-33%
|
1
-92%
|
|
EPS (Diluted) |
0.05
N/A
|
0.06
+20%
|
0.07
+17%
|
0.07
N/A
|
0.06
-14%
|
0.01
-83%
|
0
N/A
|
0.02
N/A
|
0.36
+1 700%
|
-0.03
N/A
|
-0.05
-67%
|
-0.09
-80%
|
-1.31
-1 356%
|
-0.09
+93%
|
-0.08
+11%
|
-0.13
-63%
|
-1.45
-1 015%
|
-0.13
+91%
|
-0.07
+46%
|
-0.06
+14%
|
-0.3
-400%
|
-0.79
-163%
|
-1.62
-105%
|
-1.7
-5%
|
-0.61
+64%
|
3.76
N/A
|
6.68
+78%
|
7.92
+19%
|
7.49
-5%
|
5.01
-33%
|
3.67
-27%
|
3.36
-8%
|
5.13
+53%
|
5.01
-2%
|
4.66
-7%
|
4.5
-3%
|
2.73
-39%
|
1.59
-42%
|
1.16
-27%
|
0.77
-34%
|
0.06
-92%
|